Patents-Review.com
ClassID:

20538 ⎘

A61K31/7135 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof Compounds containing heavy metals

Sub-classes:
Recent Application in this class:
#1
20260152505
2026-06-04

CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

 #2
20260130844
2026-05-14

IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM

 #3
20260014189
2026-01-15

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISORDERS COMPRISING AURANOFIN AS AN ACTIVE INGREDIENT

 #4
20250375468
2025-12-11

NOVEL RAS INHIBITORS

 #5
20250375443
2025-12-11

IDENTIFICATION AND USE OF SHP2 CONFORMATIONAL DISRUPTORS FOR CANCER TREATMENT

 #6
20250332192
2025-10-30

METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON

 #7
20250332145
2025-10-30

PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER

 #8
20250241941
2025-07-31

IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM

 #9
20250144187
2025-05-08

COMBINATION OF HYDROLASES AND ANTI-MICROORGANISM DRUGS AND USES THEREOF

 #10
20250134921
2025-05-01

ACETYLATED SIALIC ACID GLYCOCLUSTERS AND THEIR USES FOR TREATING INFECTIOUS DISEASES

 #11
20250082667
2025-03-13

THERAPEUTIC AGENTS FOR TREATMENT OF CORONAVIRUS INFECTION

 #12
20250041237
2025-02-06

HEMOGLOBIN-BASED NANOPARTICLES

 #13
20250032530
2025-01-30

USE OF AURANOFIN AS AN INHIBITOR OF ATYPICAL PROTEIN KINASE C FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

 #14
20240415869
2024-12-19

COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND THIOREDOXIN/GLUTATHIONE INHIBITORS

 #15
20240390325
2024-11-28

PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER

 #16
20240327450
2024-10-03

GLUCOSE DERIVATIVES AND ANTICANCER AGENT USING SAME

 #17
20240199620
2024-06-20

CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

 #18
20240075147
2024-03-07

Compositions having improved bioavailability of therapeutics

 #19
20240024350
2024-01-25

ANTI-CANCER COMPOSITION CONTAINING AURANOFIN AND MERCAPTO COMPOUND AND USE THEREOF

 #20
20230285441
2023-09-14

TREATMENT OF CORONAVIRUS INFECTIONS WITH AURANOFIN

 #21
20230270826
2023-08-31

ANTIVIRAL USE OF LIRAGLUTIDE AND GEFITINIB

 #22
20230241101
2023-08-03

THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS INFECTION

 #23
20230201246
2023-06-29

METAL COMPOSITIONS AND METHODS OF USE THEREOF

 #24
20230141842
2023-05-11

Compounds to Modulate Intestinal Absorption of Nutrients

 #25
20230131943
2023-04-27

ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS

 #26
20230090293
2023-03-23

ANTIBIOTICS

 #27
20230084291
2023-03-16

Iron compositions and methods of making and using them

 #28
20230008240
2023-01-12

METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON

 #29
20230001024
2023-01-05

CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF

 #30
20220362334
2022-11-17

TREATMENT AND PREVENTION OF PULMONARY INJURY

 #31
20220305125
2022-09-29

Compositions Having Improved Bioavailability of Therapeutics

 #32
20220304977
2022-09-29

Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound

 #33
20220296639
2022-09-22

SILVER-/GOLD-COMPOUNDS AND METHODS THEREOF

 #34
20220202838
2022-06-30

COMBINATIONAL THERAPIES FOR TREATMENT OF CANCER COMPRISING A BACTERIOCHLOROPHYLL DERIVATIVE

 #35
20220193109
2022-06-23

COMPOSITIONS AND METHODS FOR TREATING RAS-MUTANT CANCERS

 #36
20220168273
2022-06-02

Pharmaceutical combination for the treatment of cancer

 #37
20220111036
2022-04-14

METHOD FOR DEFINING A PERSONALIZED VACCINE AGAINST HIV/AIDS

 #38
20220017559
2022-01-20

CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS

 #39
20220000911
2022-01-06

COMBINATION OF GOLD COMPLEXES WITH OLAPARIB OR OTHER PARP1/2 INHIBITORS FOR USE IN THE TREATMENT OF CANCER RESISTANT TO SAID PARP1/2 INHIBITORS

 #40
20210369770
2021-12-02

Therapeutic Agents for Treatment of Coronavirus Infection

 #41
20210267992
2021-09-02

5-ACETAMIDOMETHYL-OXAZOLIDINONE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER

 #42
20210228591
2021-07-29

Compositions and methods of use thereof for treatment of proteinopathies

 #43
20210220319
2021-07-22

Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals

 #44
20210052632
2021-02-25

SELECTIVE PARP1 INHIBITORS TO TREAT CANCER

 #45
20200338157
2020-10-29

Compositions and methods for the treatment of fungal infections

 #46
20200317714
2020-10-08

Cyclic peroxides as prodrugs for selective delivery of agents

 #47
20200289546
2020-09-17

Compounds to modulate intestinal absorption of nutrients

 #48
20200239480
2020-07-30

CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

 #49
20200215097
2020-07-09

Methods and compositions for administration of iron

 #50
20200215096
2020-07-09

Methods and compositions for administration of iron

 #51
20200138782
2020-05-07

Pharmaceutical combination for the treatment of cancer

 #52
20190358242
2019-11-28

COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS

 #53
20190328771
2019-10-31

Methods and compositions for administration of iron

 #54
20190300885
2019-10-03

A NOVEL ROLE FOR TERMINAL RNA URIDYLATION AND RNA TURNOVER IN ONCOGENESIS

 #55
20190284224
2019-09-19

Cyclic peroxides as prodrugs for selective delivery of agents

 #56
20190274976
2019-09-12

Cancer therapy

 #57
20190224221
2019-07-25

Ultralow-power near infrared lamp light operable targeted organic nanoparticle photodynamic therapy

 #58
20190209524
2019-07-11

Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound

 #59
20190152978
2019-05-23

Chemokine receptor modulators and uses thereof

 #60
20190151405
2019-05-23

Compositions and methods for the treatment of fungal infections

 #61
20190151331
2019-05-23

Combination therapy for cancer treatment

 #62
20190125769
2019-05-02

Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative

 #63
20190083524
2019-03-21

Methods and compositions for administration of iron

 #64
20190054048
2019-02-21

Antibacterial and antifungal compounds

 #65
20190054047
2019-02-21

TREATMENT OF MALIGNANT ADRENOCORTICAL TUMOR WITH NICLOSAMIDE AND OTHER COMPOUNDS

 #66
20180264028
2018-09-20

Combination therapy for EV71 infection

 #67
20180243331
2018-08-30

Method of inhibiting quorum sensing in

#68
20180235997
2018-08-23

Methods and compositions for administration of iron

 #69
20180161430
2018-06-14

Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy

 #70
20180147234
2018-05-31

COMPOSITIONS AND METHODS FOR TREATMENT OF FIBROMYALGIA

 #71
20180036439
2018-02-08

COUPLED IDENTIFICATION AND TREATMENT OF CANCER

 #72
20180008634
2018-01-11

Kits and methods for nutrition supplementation

 #73
20170296467
2017-10-19

Chewable gelled emulsions

 #74
20170285034
2017-10-05

Methods and materials for identifying and treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiation

 #75
20170266219
2017-09-21

Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis

 #76
20170189556
2017-07-06

Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections

 #77
20170112809
2017-04-27

Pharmaceutical combination for the treatment of cancer

 #78
20160362439
2016-12-15

Cyclic peroxides as prodrugs for selective delivery of agents

 #79
20160361338
2016-12-15

Compositions of selenoorganic compounds and methods of use thereof

 #80
20160339086
2016-11-24

COMPOSITIONS AND METHODS FOR TREATING THYROID DISEASE

 #81
20160310569
2016-10-27

TUSC2 THERAPIES

 #82
20160263074
2016-09-15

Metal-salen complex compound, local anesthetic and antineoplastic drug

 #83
20160256481
2016-09-08

USE OF WATER SOLUBLE PLATINUM COMPLEX IN PREPARING DRUGS FOR PREVENTION AND TREATMENT OF CANCERS

 #84
20160237105
2016-08-18

Ruthenium carbon monoxide releasing molecules and uses thereof

 #85
20160199385
2016-07-14

Mineral amino-acid complexes of active agents

 #86
20160184493
2016-06-30

PARTIALLY ABSORBABLE FIBER-REINFORCED COMPOSITES FOR CONTROLLED DRUG DELIVERY

 #87
20160175352
2016-06-23

Kits and methods for nutrition supplementation

 #88
20160143987
2016-05-26

Compositions and methods for the treatment of fungal infections

 #89
20160106773
2016-04-21

TREATMENT FOR DISEASES RELYING ON DISCOVERY THAT THIOREDOXIN MEDIATES NITRIC OXIDE RELEASE IN CELLS

 #90
20160082033
2016-03-24

Compositions of selenoorganic compounds and methods of use thereof

 #91
20160045533
2016-02-18

Compositions of selenoorganic compounds and methods of use thereof

 #92
20160038422
2016-02-11

Tablet composition for anti-tuberculosis antibiotics

 #93
20160022729
2016-01-28

Compounds to modulate intestinal absorption of nutrients

 #94
20160018399
2016-01-21

METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS HAVING LUNG ADENOCARCINOMA CHARACTERIZED BY NEUROENDOCRINE DIFFERENTIATION

 #95
20150366884
2015-12-24

COMPOSITIONS AND METHODS FOR CANCER THERAPY

 #96
20150320756
2015-11-12

TREATMENTS OF COCCIDIOSIS WITH INTRAMUSCULAR TRIAZINE COMPOSITIONS

 #97
20150313905
2015-11-05

Treatments with triazines

 #98
20150297631
2015-10-22

TUSC2 THERAPIES

 #99
20150297630
2015-10-22

Methods and compositions for administration of iron

 #100
20150202224
2015-07-23

METHOD OF TREATING IRON DEFICIENCY ANEMIA

 #101
20150037438
2015-02-05

Chewable gelled emulsions

 #102
20150018290
2015-01-15

Inducers of hematopoiesis and fetal globin production for treatment of cytopenias and hemoglobin disorders

 #103
20140377339
2014-12-25

TUSC2 therapies

 #104
20140349955
2014-11-27

USE OF FLUORINE-CONTAINING WATER SOLUBLE PLATINUM COMPLEX IN PREPARING DRUGS FOR PREVENTION AND TREATMENT OF CANCERS

 #105
20140323437
2014-10-30

Use of metallocene compounds for cancer treatment

 #106
20140287000
2014-09-25

Tumor proliferation inhibitor containing ultrasound-sensitive substance and method for inhibiting tumor proliferation by using tumor proliferation inhibitor and low-intensity pulsed ultrasound waves

 #107
20140228744
2014-08-14

APPLIANCES AND COMPOSITIONS FOR ORAL USE AND METHODS FOR TREATING THE ORAL MUCOSA, LIPS, AND PERIORAL REGIONS

 #108
20140219996
2014-08-07

Ruthenium carbon monoxide releasing molecules and uses thereof

 #109
20140206635
2014-07-24

METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG

 #110
20140162974
2014-06-12

METHODS FOR MODULATION OF PHOSPHORUS AND FGF23

 #111
20140148398
2014-05-29

Methods of treating giardiasis

 #112
20130310445
2013-11-21

Oligonucleotide chelate complex methods

 #113
20130164387
2013-06-27

NOVEL MANNOPYRANOSIDE DERIVATIVES WITH ANTICANCER ACTIVITY

 #114
20130072673
2013-03-21

Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion

 #115
20120329767
2012-12-27

Methods and Compositions for Treating Cancer

 #116
20120315224
2012-12-13

APPLIANCES AND COMPOSITIONS FOR ORAL USE AND METHODS FOR TREATING THE ORAL MUCOSA, LIPS, AND PERIORAL REGIONS

 #117
20120308516
2012-12-06

Use of metallocene compounds for cancer treatment

 #118
20120269903
2012-10-25

NOVEL MANNOPYRANOSIDE DERIVATIVES WITH ANTICANCER ACTIVITY

 #119
20120244209
2012-09-27

TUSC2 THERAPIES

 #120
20120232037
2012-09-13

Treatment of obesity, metabolic syndrome, and diabetes with protein kinase C inhibitors

 #121
20120121726
2012-05-17

Kits and methods for nutrition supplementation

 #122
20120035130
2012-02-09

Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion

 #123
20110318265
2011-12-29

Coupled identification and treatment of cancer

 #124
20110268793
2011-11-03

Kits for nutrition supplementation

 #125
20110268771
2011-11-03

CHEWABLE GELLED EMULSIONS

 #126
20110237546
2011-09-29

Method for treating a mammal by administration of a compound having the ability to release CO

 #127
20110104308
2011-05-05

Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide

 #128
20100331274
2010-12-30

Antiaging chirally-correct mitoprotectant amino acid and peptide complexes

 #129
20100298415
2010-11-25

TARGETED SCHIFF BASE COMPLEXES

 #130
20100266644
2010-10-21

Methods and compositions for administration of iron

 #131
20100260836
2010-10-14

Kits for nutrition supplementation

 #132
20100203146
2010-08-12

INTERMITTENT DOSING STRATEGY FOR TREATING RHEUMATOID ARTHRITIS

 #133
20100152272
2010-06-17

Functionalized drugs and polymers derived therefrom

 #134
20100132794
2010-06-03

SEALED PHOTOVOLTAIC APPARATUS

 #135
20100069324
2010-03-18

Nanoparticle of glucidamin for treating tumor and preparation method thereof

 #136
20100035830
2010-02-11

Iron-carbohydrate complex compounds

 #137
20090275732
2009-11-05

Agent for improving circulatory disorder

 #138
20090130154
2009-05-21

Topical Delivery of Biological and Cosmetic Agents by Zeolites

 #139
20080113955
2008-05-15

TREATMENT OF INFANT HYPERBILIRUBINEMIA USING LOW DOSAGES OF STANNSOPORFIN

 #140
20070219120
2007-09-20

Methods for treating inflammatory disease by administering aldehydes and derivatives thereof

 #141
20070213291
2007-09-13

Therapeutically useful synthetic oligonucleotides

 #142
20070161600
2007-07-12

Methods and compositions for administration of iron

 #143
20060233890
2006-10-19

Method for treating a mammal by administration of a compound having the ability to release CO

 #144
20060183708
2006-08-17

Topical delivery of trace metals for skin care

 #145
20060172983
2006-08-03

Functionalized drugs and polymers derived therefrom

 #146
20060148900
2006-07-06

Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof

 #147
20060088481
2006-04-27

Topical oral dosage forms containing bismuth compounds

 #148
20050112021
2005-05-26

Reduction of Contaminants In Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light

 #149
20050053639
2005-03-10

Partially absorbable fiber-reinforced composites for controlled drug delivery

 #150
18419354
2025-04-22

Ebselen analogues loaded nanoemulsion